These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: 68Ga-PSMA-11 PET Represents the Tumoricidal Effect of 223Ra in a Patient With Castrate-Resistant Metastatic Prostate Cancer.
    Author: Ahmadzadehfar H, Schlenkhoff CD, Rogenhofer S, Yordanova A, Essler M.
    Journal: Clin Nucl Med; 2016 Sep; 41(9):695-6. PubMed ID: 27405025.
    Abstract:
    A 64-year-old man with prostate cancer and an increasing prostate-specific antigen (PSA) level under therapy with abiraterone acetate underwent a therapy with Ra. Before the first therapy and 4 weeks after the last cycle, the patient underwent Ga-PSMA PET, which showed a clear response of bone metastases.
    [Abstract] [Full Text] [Related] [New Search]